Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity

Scientific Reports(2024)10.1038/s41598-024-65576-2Source: DataRank Database

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity is a research paper published in Scientific Reports (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.77)OA: goldTopics (59)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Maia M. C. Bennett-Boehm ORCID,Frederik Holm Rothemejer ORCID,I. Weber ORCID,Alexander K. Regan,J. Franzen

Live enrichment

PubMed:38918496 OpenAlex:https://openalex.org/W4400012379

University of Nebraska at Omaha

Grant: GRACA and FUSE

National Institute of General Medical Sciences

Grant: P20 GM103427

Danmarks Frie Forskningsfond

Grant: DFF-7025-00022

University of Nebraska Collaboration Initiative

Grant: NR-26797

National Institute of Allergy and Infectious Diseases

Grant: R15AI178516

National Institutes of Health

Grant: 3P20GM103427-23S2

Nebraska Research Network in Functional Genomics

National Institutes of Health

Grant: 1R15AI178516-01

Dissecting the Differential Impacts of Toll-like Receptor 9 Agonism on the Capacity of Human Natural Killer Cells to Mediate Target Cell Killing

FWCI

0.77

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-024-65576-2.pdf

publisherhttps://www.nature.com/articles/s41598-024-65576-2.pdf

publisherhttps://www.nature.com/articles/s41598-024-65576-2

journalhttps://doi.org/10.1038/s41598-024-65576-2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38918496

Fields of Study

Immune Cell Function and InteractionImmune Response and InflammationImmunotherapy and Immune Responses0301 basic medicine0303 health sciences03 medical and health sciencesHumansKiller Cells, NaturalAntibody-Dependent Cell CytotoxicityToll-Like Receptor 9Leukocytes, MononuclearLymphocyte ActivationReceptors, IgGCell Line, TumorCytotoxicity, Immunologic

MeSH Terms

Antibody-Dependent Cell CytotoxicityCytotoxicity, ImmunologicHumansKiller Cells, NaturalLeukocytes, MononuclearLymphocyte ActivationReceptors, IgGCell Line, TumorToll-Like Receptor 9

Keywords

AgonismCytotoxicityCellAntibodyTLR9Cell biologyImmunologyCell mediated immunityChemistryBiologyImmune systemImmunityIn vitroBiochemistryGene expressionGeneCytotoxicity, ImmunologicHuman NK cellsScienceQReceptors, IgGRAntibody-Dependent Cell CytotoxicityLymphocyte ActivationArticleImmunophenotypingKiller Cells, NaturalTLR9 agonistToll-Like Receptor 9Cell Line, TumorLeukocytes, MononuclearMedicineHumansDirect killingADCC

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being